Cyclooxygenase-1 signaling is required for vascular tube formation during development

Dev Biol. 2005 Jun 1;282(1):274-83. doi: 10.1016/j.ydbio.2005.03.014.

Abstract

Prostaglandin endoperoxide synthases (PTGS), commonly referred to as cyclooxygenases (COX-1 and COX-2), catalyze the key step in the synthesis of biologically active prostaglandins (PGs), the conversion of arachidonic acid (AA) into prostaglandin H2 (PGH2). Although COX and prostaglandins have been implicated in a wide variety of physiologic processes, an evaluation of the role of prostaglandins in early mammalian development has been difficult due to the maternal contribution of prostaglandins from the uterus: COX null mouse embryos develop normally during embryogenesis. Here, we verify that inhibition of COX-1 results in zebrafish gastrulation arrest and shows that COX-1 expression becomes restricted to the posterior mesoderm during somitogenesis and to posterior mesoderm organs at pharyngula stage. Inhibition of COX-1 signaling after gastrulation results in defective vascular tube formation and shortened intersomitic vessels in the posterior body region. These defects are rescued completely by PGE(2) treatment or, to a lesser extent, by PGF(2alpha), but not by other prostaglandins, such as PGI(2), TxB(2), or PGD(2). Functional knockdown of COX-1 using antisense morpholino oligonucleotide translation interference also results in posterior vessel defect in addition to enlarged posterior nephric duct, phenocopying the defects caused by inhibition of COX-1 activity. Together, we provide the first evidence that COX-1 signaling is required for development of posterior mesoderm organs, specifically in the vascular tube formation and posterior nephric duct development.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Vessels / drug effects
  • Blood Vessels / embryology*
  • Cyclooxygenase 1
  • Cyclooxygenase Inhibitors / pharmacology*
  • Dinoprostone / pharmacology
  • Gastrula / drug effects
  • Gastrula / physiology*
  • In Situ Hybridization
  • Mesoderm / metabolism
  • Microinjections
  • Oligonucleotides, Antisense / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Zebrafish / embryology*

Substances

  • Cyclooxygenase Inhibitors
  • Oligonucleotides, Antisense
  • Cyclooxygenase 1
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone